Coronavirus Latest News

Johnson & Johnson coronavirus vaccine gets better boost from Moderna or Pfizer, US study shows

People who got Johnson & Johnson Inc’s Covid-19 vaccine as a first shot had a stronger immune response when boosted with vaccines from Pfizer Inc/BioNTech SE or Moderna Inc, a study run by the National Institutes of Health showed on Wednesday.The study, which is preliminary and has not been peer reviewed, is the latest challenge to J&J’s efforts to use its Covid-19 vaccine as a booster in the United States.The study, which included more than 450 adults who received initial shots from Pfizer,…

Read the original article at South China Morning Post

Related Articles

Back to top button